Valuing assets
has never been easier
than with our app

Metrics, sentiment, activity and AI.

Eye

About us

loop eye
WE

We are

A team, that aims to bring light to the trade world, like Prometheus. People should get a simple tool for assessing an asset.

WE

EYE watching

Sentiment in the news, in chats. The slightest changes in the pattern. The activities of developers and whales. All this under close supervision

WE

Token

Will be a way, of supporting and influencing, every step of our way and the final product that we present.

Roadmap

Arrow bottom

V0.1

  • Telegram bot with project chat sentiment analysis, metrics analysis, holders and AI rating.
  • Landing page.
    • Arrow bottom

    V0.2

  • Analysis of project social networks, developer activity analysis. Adding your search history.
  • Going beyond HypurrFun and adding token analysis from the Hyperliquid spot.
  • Token launch.

    • V1.0

    Release of a full-fledged application with our own AI model capable of generating it's own opinion about project or token. Look for cooperation in the field. Further development together with the community.

    Arrow bottom

    V0.3

  • Application optimization. The ability to track changes in sentiment in the project chat in real time. Chat with AI about the token.
    • Arrow bottom

    V0.5

  • Implementation of functionality into the site. Backward compatibility between the site and Telegram Bot
    • Arrow bottom

    V0.4

  • Analysis of news around the token selected by the user and tracking them in real time.
  • Expansion of available ecosystems for analysis.

    • Launch app

    ellipse green

    HyperEye Bot

    A high-functional Telegram bot for evaluating a token or project, tracking news, and monitoring holder activities.

    ellipse green

    HyperEye WebApp

    A web app with backward compatibility between site and Telegram bot, for convenient storage of your search history and sorting your AI-chats.

    Coming soon

    logo

    Hyper
    Eye

    Privacy policy User agreement

    © 2024 All right reserved.